Related Experiment Video
Updated: Dec 15, 2025

08:01
Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
43.9K
Testing Amyloid Cross-Toxicity in the Vertebrate Brain
Gabriela Henríquez1, Lois Mendez2, Ariel N Schmid2
1Department of Environmental Science and Engineering, The University of Texas at El Paso (UTEP), 500 W. University Avenue, El Paso, Texas 79968, United States.
ACS Omega
|July 9, 2020
Summary
Foreign amyloid proteins can infiltrate neurons and interact with different native proteins, offering new insights into neurodegenerative diseases like Parkinson's. This study introduces a novel method for studying cross-toxicity in the brain.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Amyloid proteins (e.g., amyloid β, α-synuclein) exhibit prion-like properties and can induce misfolding in other proteins.
- Emerging evidence suggests these amyloids can also seed misfolding in proteins with different sequences.
Purpose of the Study:
- To develop and utilize a tool for assessing neurohistochemical changes when a foreign amyloid enters heterotypic neurons.
- To investigate the cross-seeding potential of amyloid β (Aβ) in neurons expressing different endogenous amyloids.
Main Methods:
- Stereotaxic introduction of Aβ into the rodent tegmental area of the mid-brain.
- Neurohistochemical analysis to detect Aβ infiltration and colocalization within nigral neurons.
- Examination of interactions between introduced Aβ and endogenous α-synuclein.
Main Results:
- Aβ successfully infiltrated nigral neurons in the substantia nigra.
- Aβ was found colocalized with α-synuclein, an endogenous amyloid in the substantia nigra.
- The stereotaxic method minimized confounding variables present in transgenic models.
Conclusions:
- Foreign amyloids can interact with and potentially disrupt endogenous proteins like α-synuclein, which is implicated in Parkinson's disease.
- The developed stereotaxic technique provides a refined model for studying neurodegenerative cross-toxicity.
- Findings may help explain the high frequency of clinical comorbidities in neurodegenerative diseases.

